Using Serial Analysis of Gene Expression to Identify Tumor Markers and Antigens

Por Riggins, Gregory J.
Publicado em 2001

OPTIMIZATION OF DEMETHYLATING THERAPY FOR IDH1 MUTANT GLIOMAS

Por Riggins, Gregory J., Borodovsky, Alexandra
Publicado em 2014

Navigating the human transcriptome

Por Strausberg, Robert L., Riggins, Gregory J.
Publicado em 2001

Caveolin-1, caveolae, and glioblastoma

Por Parat, Marie-Odile, Riggins, Gregory J.
Publicado em 2012

Molecular Targeting of Glioblastoma: Drug Discovery and Therapies

Por Bai, Ren-Yuan, Staedtke, Verena, Riggins, Gregory J.
Publicado em 2011

Altered cancer cell metabolism in gliomas with mutant IDH1 or IDH2

Por Borodovsky, Alexandra, Seltzer, Meghan J., Riggins, Gregory J.
Publicado no Curr Opin Oncol (2012)

The Hippo signaling pathway and translational opportunities for brain cancers

Por Baia, Gilson S, Caballero, Otavia L, Riggins, Gregory J
Publicado no CNS Oncol (2012)

Cancer biomarker discovery for cholangiocarcinoma: the high-throughput approaches

Por Silsirivanit, Atit, Sawanyawisuth, Kanlayanee, Riggins, Gregory J., Wongkham, Chaisiri
Publicado no J Hepatobiliary Pancreat Sci (2014)

Identification of astrocytoma associated genes including cell surface markers

Por Boon, Kathy, Edwards, Jennifer B, Eberhart, Charles G, Riggins, Gregory J
Publicado em 2004

Sodium ion channel mutations in glioblastoma patients correlate with shorter survival

Por Joshi, Avadhut D, Parsons, D Williams, Velculescu, Victor E, Riggins, Gregory J
Publicado em 2011

Mebendazole and a non-steroidal anti-inflammatory combine to reduce tumor initiation in a colon cancer preclinical model

Por Williamson, Tara, Bai, Ren-Yuan, Staedtke, Verena, Huso, David, Riggins, Gregory J.
Publicado no Oncotarget (2016)

Effective treatment of diverse medulloblastoma models with mebendazole and its impact on tumor angiogenesis

Por Bai, Ren-Yuan, Staedtke, Verena, Rudin, Charles M., Bunz, Fred, Riggins, Gregory J.
Publicado no Neuro Oncol (2015)

A novel small molecule that selectively inhibits glioblastoma cells expressing EGFRvIII

Por Trembath, Dimitri G, Lal, Anita, Kroll, David J, Oberlies, Nicholas H, Riggins, Gregory J
Publicado em 2007

Antiparasitic mebendazole shows survival benefit in 2 preclinical models of glioblastoma multiforme

Por Bai, Ren-Yuan, Staedtke, Verena, Aprhys, Colette M., Gallia, Gary L., Riggins, Gregory J.
Publicado em 2011

OTX2 Represses Myogenic and Neuronal Differentiation in Medulloblastoma Cells

Por Bai, Ren-Yuan, Staedtke, Verena, Lidov, Hart G., Eberhart, Charles G., Riggins, Gregory J.
Publicado no Cancer Res (2012)

Re-expression of ABI3BP Suppresses Thyroid Tumor Growth by Promoting Senescence and Inhibiting Invasion

Por Latini, Flavia R. M., Hemerly, Jefferson P., Oler, Gisele, Riggins, Gregory J., Cerutti, Janete M.
Publicado em 2008

Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells

Por Weber, Genevieve L., Parat, Marie-Odile, Binder, Zev A., Gallia, Gary L., Riggins, Gregory J.
Publicado em 2011

Gene Expression Profiling of Papillary Thyroid Carcinoma Identifies Transcripts Correlated with BRAF Mutational Status and Lymph Node Metastasis

Por Oler, Gisele, Camacho, Cléber P., Hojaij, Flávio C., Michaluart, Pedro, Riggins, Gregory J., Cerutti, Janete M.
Publicado em 2008

Evaluation of retinoic acid therapy for OTX2-positive medulloblastomas

Por Bai, Renyuan, Siu, I-Mei, Tyler, Betty M., Staedtke, Verena, Gallia, Gary L., Riggins, Gregory J.
Publicado em 2010

Evaluation of Tyrosine Kinase Inhibitor Combinations for Glioblastoma Therapy

Por Joshi, Avadhut D., Loilome, Watcharin, Siu, I-Mei, Tyler, Betty, Gallia, Gary L., Riggins, Gregory J.
Publicado em 2012